Abstract
High blood pressure is the most important risk factor for cardiovascular disease. With the information on systolic blood pressure from the recently published meta-analysis of prospective studies, we calculated the reductions in stroke and ischaemic heart disease with control of all hypertensives to a systolic blood pressure of 140 mmHg. For adults there would be a reduction of 28–44% in stroke and 20–35% in ischaemic heart disease depending on age. In the UK, this would prevent approximately 21 400 stroke deaths and 41 400 ischaemic heart disease deaths each year. Around half of those who suffer a stroke or ischaemic heart disease survive, there would be a proportionate decrease in these people as well. These amount to approximately 42 800 strokes and 82 800 ischaemic heart diseases saved, making a total of 125 600 events saved a year in the UK. This would result in a reduction in disability and major cost savings both to individuals, their families and the Health Service. The blood pressure levels and control of blood pressure in many countries are similar to those in the UK, so the reductions in stroke and ischaemic heart disease worldwide, if the same control of high blood pressure could be obtained, would be immense.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ezzati M et al; the Comparative Risk Assessment Collaborating Group. Selected major risk factors and global and regional burden of disease. Lancet 2002; 360: 1347–1360.
Murray CJL et al. Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk. Lancet 2003; 361: 717–725.
Prospective studies collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903–1913.
Primatesta P, Brookes M, Poulter NR . Improved hypertension management and control: results from the Health Survey for England 1998. Hypertension 2001; 38: 827–832.
Coronary heart disease statistics. British Heart Foundation Statistics Database 2002. http://www.dphpc.ox.ac.uk/bhfhprg/stats/2000/index.html.
MacMahon S et al. Blood pressure, stroke, and coronary heart disease, Part 1, Prolonged differences in BP: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335: 765–774.
SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265: 3255–3264.
Staessen JA et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 1997; 350: 757–764.
The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Anti-hypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288: 2981–2997.
Hansson L et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 1998; 351: 1755–1762.
Brown MJ et al. Better blood pressure control: how to combine drugs. J Hum Hypertens 2003; 17: 81–86.
Acknowledgements
We thank Dr Paola Primatesta for providing us with the average blood pressure of hypertensives in the Health Survey for England 1998.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
He, F., MacGregor, G. Cost of poor blood pressure control in the UK: 62 000 unnecessary deaths per year. J Hum Hypertens 17, 455–457 (2003). https://doi.org/10.1038/sj.jhh.1001581
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jhh.1001581
Keywords
This article is cited by
-
Therapeutic RNA-silencing oligonucleotides in metabolic diseases
Nature Reviews Drug Discovery (2022)
-
Association between attendance at outpatient follow-up appointments and blood pressure control among patients with hypertension
BMC Cardiovascular Disorders (2020)
-
LC–MS/MS Determination of Antihypertension Drugs in Rat Plasma and Urine: Applications to Pharmacokinetics
Chromatographia (2018)
-
Updated National and International Hypertension Guidelines: A Review of Current Recommendations
Drugs (2014)
-
Clinical Implications of the 2013 ESH/ESC Hypertension Guidelines: Targets, Choice of Therapy, and Blood Pressure Monitoring
Drugs in R&D (2014)